Vera Therapeutics is trading 8.3% down in pre-market at $27.50; no fresh company announcement explaining the decline was identified. - On October 27, shares closed at $29.99 after a 5.97% gain. - Positive ORIGIN 3 results announced October 22 do not establish the cause of the October 28 decline. Broader market indicators are mixed, and no volume or activity-level data is available in the supplied price context.